<div class="crocodoc-c3wtfV crocodoc-page-text" style="width:593.76pt; height:843.4266pt;">
<div class="tb f727" style="font-size:6.53pt;top:819.06pt;left:497.19pt;"><span class="tx" style="width:74.6pt;height:8.5pt;border-width:0 0 11pt 11pt;">Innovation for patient care</span><span class="tx" style="font-size:3.86pt;left:84.6pt;width:2.3pt;height:5pt;border-width:2pt 10pt 12pt 0;">*</span><br/></div>
<div class="tb f734" style="font-size:12pt;top:790.64pt;left:62.51pt;"><span class="tx" style="width:357.9pt;height:14.9pt;border-width:0 10pt 11pt 11pt;">Pour plus d&#x2019;informations, consultez la notice du m&#xe9;dicament.</span><br/></div>
<div class="tb f738" style="font-size:16pt;top:47.01pt;left:309.28pt;"><span class="tx" style="width:184.6pt;height:20.6pt;border-width:0 0 0 11pt;">L.<span style="width:0.44em;">P</span>. 3 mg, L.<span style="width:0.44em;">P</span>. 11,25 mg</span><span class="tx f743" style="word-spacing:-3.13pt;left:194.6pt;width:4.8pt;height:19.1pt;border-width:1pt 10pt 0 0;">&nbsp; </span><br/><span class="tx" style="top:16pt;width:116.1pt;height:20.6pt;border-width:0 83pt 11pt 11pt;">et L.<span style="width:0.44em;">P</span>. 22,5 mg</span><br/></div>
<div class="tb f752" style="font-size:10pt;letter-spacing:-0.1pt;top:91.1pt;left:19.91pt;"><span class="tx f734" style="font-size:30pt;letter-spacing:0pt;width:106.1pt;height:37.2pt;border-width:0 221pt 0 236pt;">GUIDE  </span><br/><span class="tx f748" style="font-size:18.3pt;letter-spacing:0pt;top:33.7pt;width:477.1pt;height:22.7pt;border-width:0 0 39pt 23pt;">pour la pr&#xe9;paration et l&#x2019;administration de D&#xe9;capeptyl</span><span class="tx f748" style="font-size:10.67pt;letter-spacing:0pt;top:33.7pt;left:499.4pt;width:8.5pt;height:13.2pt;border-width:1pt 0 47pt 0;">&#xae;</span><span class="tx f748" style="font-size:18.3pt;letter-spacing:0pt;top:33.7pt;left:508pt;width:30.4pt;height:22.7pt;border-width:0 23pt 39pt 0;">&nbsp;L.<span style="width:0.35em;">P</span>.</span><br/><span class="tx f738" style="word-spacing:0.23pt;top:93.9pt;width:541.7pt;height:12.9pt;border-width:0 10pt 0 11pt;">D&#xe9;capeptyl L.<span style="width:0.43em;">P</span>. 3 mg, poudre et solvant pour suspension injectable (I.M.) forme &#xe0; lib&#xe9;ration prolong&#xe9;e sur </span><span class="tx f738" style="top:105.9pt;width:42.9pt;height:12.9pt;border-width:0 0 3pt 11pt;">28 jours.</span><span class="tx f738" style="font-size:5.83pt;letter-spacing:-0.06pt;top:105.9pt;left:52.9pt;width:9pt;height:7.5pt;border-width:1pt 0 8pt 0;">(1)</span><span class="tx f738" style="letter-spacing:0pt;top:105.9pt;left:61.9pt;width:3.1pt;height:12.9pt;border-width:0 497pt 3pt 0;"> </span><br/><span class="tx f743" style="word-spacing:1.07pt;top:121.1pt;width:55.5pt;height:12pt;border-width:0 0 1pt 11pt;">Indications :&nbsp;</span><span class="tx f743" style="word-spacing:1.07pt;top:121.1pt;left:65.5pt;width:98.8pt;height:12pt;border-width:0 0 1pt 0;">Cancer de la prostate :</span><span class="tx f743" style="letter-spacing:0pt;top:121.1pt;left:164.2pt;width:3.4pt;height:12pt;border-width:0 0 1pt 0;">&nbsp;</span><span class="tx" style="word-spacing:0.93pt;top:121.1pt;left:167.7pt;width:383.1pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">Traitement du cancer de la prostate localement avanc&#xe9;, seul ou en traitement concomitant et </span><span class="tx" style="word-spacing:0.47pt;top:133.3pt;width:540.8pt;height:11.8pt;border-width:0 11pt 1pt 11pt;">adjuvant &#xe0; la radioth&#xe9;rapie. Traitement du cancer de la prostate m&#xe9;tastatique. Un effet favorable du m&#xe9;dicament est d&#x2019;autant plus net </span><span class="tx" style="word-spacing:0.03pt;top:145.1pt;width:338.1pt;height:11.8pt;border-width:0pt 0 1pt 11pt;">et plus fr&#xe9;quent que le patient n&#x2019;a pas re&#xe7;u auparavant un autre traitement hormonal.</span><span class="tx f743" style="letter-spacing:0pt;top:145.1pt;left:348.1pt;width:2.5pt;height:12pt;border-width:0 0 1pt 0;">&nbsp;</span><span class="tx f743" style="word-spacing:0.04pt;top:145.1pt;left:350.5pt;width:74.2pt;height:12pt;border-width:0 0 1pt 0;">Pubert&#xe9; pr&#xe9;coce :</span><span class="tx f743" style="letter-spacing:0pt;top:145.1pt;left:424.7pt;width:2.4pt;height:12pt;border-width:0 0 1pt 0;">&nbsp;</span><span class="tx" style="word-spacing:0.03pt;top:145.1pt;left:427.1pt;width:123.6pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">(avant 8 ans chez la <span style="width:0.56em;">fi</span>lle, avant<span style="width:0em;">&nbsp;</span> </span><span class="tx" style="word-spacing:-0.25pt;top:157.1pt;width:91.5pt;height:11.8pt;border-width:0pt 0 1pt 11pt;">10 ans chez le gar&#xe7;on).&nbsp;</span><span class="tx f743" style="word-spacing:-0.29pt;top:157.1pt;left:101.5pt;width:65.5pt;height:12pt;border-width:0 0 1pt 0;">Endom&#xe9;triose :&nbsp;</span><span class="tx" style="word-spacing:-0.25pt;top:157.1pt;left:167pt;width:383.8pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">&#xe0; localisation g&#xe9;nitale et extrag&#xe9;nitale (du stade I au stade IV) : La dur&#xe9;e du traitement est limit&#xe9;e </span><span class="tx" style="word-spacing:0.75pt;top:169.3pt;width:540.8pt;height:11.8pt;border-width:0 11pt 1pt 11pt;">&#xe0; 6 mois (cf. Effets ind&#xe9;sirables). Il n&#x2019;est pas souhaitable d&#x2019;entreprendre une seconde cure par la triptor&#xe9;line ou par un autre analogue </span><span class="tx" style="word-spacing:1.1pt;top:181.1pt;width:47.7pt;height:11.8pt;border-width:0pt 0 1pt 11pt;">de la GnRH.</span><span class="tx f743" style="letter-spacing:0pt;top:181.1pt;left:57.7pt;width:3.6pt;height:12pt;border-width:0 0 1pt 0;">&nbsp;</span><span class="tx f743" style="word-spacing:1.27pt;top:181.1pt;left:61.3pt;width:95.4pt;height:12pt;border-width:0 0 1pt 0;">Inf&#xe9;condit&#xe9; f&#xe9;minine :</span><span class="tx f743" style="letter-spacing:0pt;top:181.1pt;left:156.7pt;width:3.6pt;height:12pt;border-width:0 0 1pt 0;">&nbsp;</span><span class="tx" style="word-spacing:1.1pt;top:181.1pt;left:160.3pt;width:390.4pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">Traitement compl&#xe9;mentaire, en association avec les gonadotrophines (hMG, FSH, hCG), au cours </span><span class="tx" style="word-spacing:-0.12pt;top:193.1pt;width:219.7pt;height:11.8pt;border-width:0pt 0 1pt 11pt;">d&#x2019;une induction de l&#x2019;ovulation en vue d&#x2019;une f&#xe9;condation&nbsp;</span><span class="tx f756" style="word-spacing:-0.12pt;top:193.1pt;left:229.7pt;width:29.1pt;height:11.8pt;border-width:0pt 0 1pt 0;">in vitro&nbsp;</span><span class="tx" style="word-spacing:-0.12pt;top:193.1pt;left:258.8pt;width:162.2pt;height:11.8pt;border-width:0pt 0 1pt 0;">suivie d&#x2019;un transfert d&#x2019;embryon (FIVETE).&nbsp;</span><span class="tx f743" style="word-spacing:-0.14pt;top:193.1pt;left:421.1pt;width:130pt;height:12pt;border-width:0 11pt 1pt 0;">Traitement pr&#xe9;-op&#xe9;ratoire des </span><span class="tx f743" style="word-spacing:-0.17pt;top:205.1pt;width:76.6pt;height:12pt;border-width:0 0 1pt 11pt;"><span style="width:0.61em;">fi</span>bromes ut&#xe9;rins :&nbsp;</span><span class="tx" style="word-spacing:-0.15pt;top:205.1pt;left:86.6pt;width:464.1pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">associ&#xe9;s &#xe0; une an&#xe9;mie (avec un taux d&#x2019;h&#xe9;moglobine inf&#xe9;rieur ou &#xe9;gal &#xe0; 8 g/dl), dans le cas o&#xf9; une r&#xe9;duction de la taille </span><span class="tx" style="word-spacing:0.13pt;top:217.3pt;width:540.7pt;height:11.8pt;border-width:0 11pt 1pt 11pt;">du <span style="width:0.56em;">fi</span>brome est n&#xe9;cessaire pour faciliter ou modi<span style="width:0.56em;">fi</span>er la technique op&#xe9;ratoire : chirurgie endoscopique, chirurgie transvaginale. La dur&#xe9;e du </span><span class="tx" style="top:229.3pt;width:123.2pt;height:11.8pt;border-width:0 429pt 3pt 11pt;">traitement est limit&#xe9;e &#xe0; 3 mois.</span><br/><span class="tx f738" style="word-spacing:-0.02pt;top:243.6pt;width:541.6pt;height:12.9pt;border-width:0 10pt 0 11pt;">D&#xe9;capeptyl L.<span style="width:0.43em;">P</span>. 11,25 mg, poudre et solvant pour suspension injectable (I.M.) forme &#xe0; lib&#xe9;ration prolong&#xe9;e </span><span class="tx f738" style="top:255.6pt;width:53.3pt;height:12.9pt;border-width:0 0 3pt 11pt;">sur 3 mois.</span><span class="tx f738" style="font-size:5.83pt;letter-spacing:-0.06pt;top:255.6pt;left:63.3pt;width:10.7pt;height:7.5pt;border-width:1pt 488pt 8pt 0;">&nbsp;(2)</span><br/><span class="tx f743" style="word-spacing:1.07pt;top:270.8pt;width:55.5pt;height:12pt;border-width:0 0 1pt 11pt;">Indications :&nbsp;</span><span class="tx f743" style="word-spacing:1.07pt;top:270.8pt;left:65.5pt;width:98.8pt;height:12pt;border-width:0 0 1pt 0;">Cancer de la prostate :</span><span class="tx f743" style="letter-spacing:0pt;top:270.8pt;left:164.2pt;width:3.4pt;height:12pt;border-width:0 0 1pt 0;">&nbsp;</span><span class="tx" style="word-spacing:0.93pt;top:270.8pt;left:167.7pt;width:383.1pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">Traitement du cancer de la prostate localement avanc&#xe9;, seul ou en traitement concomitant et </span><span class="tx" style="word-spacing:-0.08pt;top:283pt;width:540.8pt;height:11.8pt;border-width:0 11pt 1pt 11pt;">adjuvant &#xe0; la radioth&#xe9;rapie. Traitement du cancer de la prostate m&#xe9;tastatique. Un effet favorable du m&#xe9;dicament est d&#x2019;autant plus net et </span><span class="tx" style="word-spacing:-0.46pt;top:294.8pt;width:323.2pt;height:11.8pt;border-width:0pt 0 1pt 11pt;">plus fr&#xe9;quent que le patient n&#x2019;a pas re&#xe7;u auparavant un autre traitement hormonal.&nbsp;</span><span class="tx f743" style="word-spacing:-0.53pt;top:294.8pt;left:333.2pt;width:63.2pt;height:12pt;border-width:0 0 1pt 0;">Endom&#xe9;triose :</span><span class="tx" style="word-spacing:-0.46pt;top:294.8pt;left:396.4pt;width:154.4pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">&nbsp;&#xe0; localisation g&#xe9;nitale et extrag&#xe9;nitale </span><span class="tx" style="word-spacing:-0.2pt;top:307pt;width:540.7pt;height:11.8pt;border-width:0 11pt 1pt 11pt;">(du stade I au stade IV). La dur&#xe9;e du traitement est limit&#xe9;e &#xe0; 6 mois (voir rubrique 4.8). Il n&#x2019;est pas souhaitable d&#x2019;entreprendre une seconde </span><span class="tx" style="word-spacing:0.27pt;top:318.8pt;width:241pt;height:11.8pt;border-width:0pt 0 1pt 11pt;">cure par la triptor&#xe9;line ou par un autre analogue de la GnRH.&nbsp;</span><span class="tx f743" style="word-spacing:0.31pt;top:318.8pt;left:251pt;width:112pt;height:12pt;border-width:0 0 1pt 0;">Pubert&#xe9; pr&#xe9;coce centrale :</span><span class="tx" style="word-spacing:0.27pt;top:318.8pt;left:363pt;width:187.8pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">&nbsp;(avant 8 ans chez la <span style="width:0.56em;">fi</span>lle, avant 10 ans chez le </span><span class="tx" style="top:331pt;width:31.4pt;height:11.8pt;border-width:0 520pt 3pt 11pt;">gar&#xe7;on).</span><br/><span class="tx f738" style="top:345.2pt;width:472.4pt;height:12.9pt;border-width:0 0 3pt 11pt;">D&#xe9;capeptyl L.<span style="width:0.43em;">P</span>. 22,5 mg, poudre et solvant pour suspension injectable &#xe0; lib&#xe9;ration prolong&#xe9;e.</span><span class="tx f738" style="font-size:5.83pt;letter-spacing:-0.06pt;top:345.2pt;left:482.4pt;width:10.7pt;height:7.5pt;border-width:1pt 69pt 8pt 0;">&nbsp;(3)</span><br/><span class="tx f743" style="word-spacing:0.14pt;top:360.4pt;width:51.1pt;height:12pt;border-width:0 0 1pt 11pt;">Indications :</span><span class="tx" style="word-spacing:0.12pt;top:360.4pt;left:61.1pt;width:489.7pt;height:11.8pt;border-width:0pt 11pt 1pt 0;">&nbsp;Traitement du cancer de la prostate hormono-d&#xe9;pendant localement avanc&#xe9; ou m&#xe9;tastatique. D&#xe9;capeptyl L.P. 22,5 mg est </span><span class="tx" style="top:372.6pt;width:514.3pt;height:11.8pt;border-width:0 37pt 11pt 11pt;">indiqu&#xe9; en traitement concomitant et adjuvant &#xe0; la radioth&#xe9;rapie du cancer de la prostate hormono-d&#xe9;pendant localement avanc&#xe9;.</span><br/></div>
<div class="tb f752" style="font-size:7.2pt;top:755.97pt;left:17.96pt;"><span class="tx" style="width:54.3pt;height:9.4pt;border-width:0 0 0 11pt;">1) RCP D&#xe9;capeptyl</span><span class="tx" style="font-size:4.2pt;left:64.3pt;width:2.6pt;height:5.5pt;border-width:1pt 0 4pt 0;">&#xae;</span><span class="tx" style="left:66.9pt;width:28.4pt;height:9.4pt;border-width:0 24pt 0 0;">&nbsp;L.P. 3 mg. </span><span class="tx" style="top:9pt;width:54.3pt;height:9.4pt;border-width:0 0 0 11pt;">2) RCP D&#xe9;capeptyl</span><span class="tx" style="font-size:4.2pt;top:9pt;left:64.3pt;width:2.6pt;height:5.5pt;border-width:1pt 0 4pt 0;">&#xae;</span><span class="tx" style="top:9pt;left:66.9pt;width:42.1pt;height:9.4pt;border-width:0 10pt 0 0;">&nbsp;L.P. 11,25 mg. </span><span class="tx" style="top:18pt;width:54.3pt;height:9.4pt;border-width:0 0 11pt 11pt;">3) RCP D&#xe9;capeptyl</span><span class="tx" style="font-size:4.2pt;top:18pt;left:64.3pt;width:2.6pt;height:5.5pt;border-width:1pt 0 14pt 0;">&#xae;</span><span class="tx" style="top:18pt;left:66.9pt;width:37.9pt;height:9.4pt;border-width:0 14pt 11pt 0;">&nbsp;L.P. 22,5 mg.</span><br/></div>
<div class="tb f738" style="font-size:9pt;top:551.82pt;left:45.16pt;"><span class="tx f748" style="width:54.2pt;height:11.2pt;border-width:0pt 0 0 11pt;">Formulation&nbsp;</span><span class="tx" style="left:64.2pt;width:71pt;height:11.6pt;border-width:0 10pt 0 0;">28 jours (3 mg) </span><span class="tx" style="top:10.8pt;width:109.3pt;height:11.6pt;border-width:0 18pt 11pt 19pt;">VOIE INTRAMUSCULAIRE</span><br/></div>
<div class="tb f738" style="font-size:9pt;top:551.82pt;left:219.98pt;"><span class="tx f748" style="width:54.2pt;height:11.2pt;border-width:0pt 0 0 11pt;">Formulation&nbsp;</span><span class="tx" style="left:64.2pt;width:84.2pt;height:11.6pt;border-width:0 10pt 0 0;">3 mois (11,25 mg) </span><span class="tx" style="top:10.8pt;width:109.3pt;height:11.6pt;border-width:0 25pt 11pt 26pt;">VOIE INTRAMUSCULAIRE</span><br/></div>
<div class="tb f738" style="font-size:9pt;top:551.82pt;left:404.18pt;"><span class="tx f748" style="width:54.2pt;height:11.2pt;border-width:0pt 0 0 11pt;">Formulation&nbsp;</span><span class="tx" style="left:64.2pt;width:78.7pt;height:11.6pt;border-width:0 10pt 0 0;">6 mois (22,5 mg) </span><span class="tx" style="top:10.8pt;width:109.3pt;height:11.6pt;border-width:0 22pt 11pt 23pt;">VOIE INTRAMUSCULAIRE</span><br/></div>
<div class="tb f748" style="font-size:8pt;top:587.93pt;left:189.18pt;"><span class="tx f738" style="width:8.4pt;height:10.3pt;border-width:0 0 0 11pt;">&#x2022;&nbsp;</span><span class="tx" style="left:18.4pt;width:175.6pt;height:9.9pt;border-width:0pt 0 0 0;">1 <span style="width:0.46em;">fl</span>acon contenant la poudre de D&#xe9;capeptyl</span><span class="tx" style="font-size:4.66pt;left:194pt;width:3.7pt;height:5.8pt;border-width:1pt 0 4pt 0;">&#xae;</span><span class="tx" style="left:197.7pt;width:13.3pt;height:9.9pt;border-width:0pt 10pt 0 0;">&nbsp;L.<span style="width:0.35em;">P</span>. </span><span class="tx f738" style="top:9.6pt;width:8.4pt;height:10.3pt;border-width:0 0 0 45pt;">&#x2022;&nbsp;</span><span class="tx" style="top:9.6pt;left:51.9pt;width:124.6pt;height:9.9pt;border-width:0pt 44pt 0 0;">1 ampoule contenant le solvant </span><span class="tx f738" style="top:19.2pt;width:8.4pt;height:10.3pt;border-width:0 0 11pt 87pt;">&#x2022;&nbsp;</span><span class="tx" style="top:19.2pt;left:93.9pt;width:40.5pt;height:9.9pt;border-width:0pt 86pt 11pt 0;">1 seringue</span><br/></div>
<div class="tb f760" style="font-size:8pt;word-spacing:-0.3pt;top:632.21pt;left:84.81pt;"><span class="tx" style="width:46pt;height:10.1pt;border-width:0 10pt 11pt 11pt;">2 AIGUILLES</span><br/></div>
<div class="tb f760" style="font-size:8pt;word-spacing:-0.3pt;top:632.21pt;left:266.23pt;"><span class="tx" style="width:46pt;height:10.1pt;border-width:0 10pt 11pt 11pt;">2 AIGUILLES</span><br/></div>
<div class="tb f760" style="font-size:8pt;word-spacing:-0.3pt;top:632.21pt;left:447.64pt;"><span class="tx" style="width:46pt;height:10.1pt;border-width:0 10pt 11pt 11pt;">2 AIGUILLES</span><br/></div>
<div class="tb f760" style="font-size:9pt;top:656.38pt;left:25.8pt;"><span class="tx" style="width:102pt;height:11.4pt;border-width:0 0 11pt 11pt;">RECONSTITUTION&nbsp;</span><span class="tx" style="left:112pt;width:76.6pt;height:11.4pt;border-width:0 0 11pt 0;">INJECTION&nbsp;</span><span class="tx" style="left:188.6pt;width:107.7pt;height:11.4pt;border-width:0 0 11pt 0;">RECONSTITUTION&nbsp;</span><span class="tx" style="left:296.2pt;width:76.6pt;height:11.4pt;border-width:0 0 11pt 0;">INJECTION&nbsp;</span><span class="tx" style="left:372.8pt;width:102pt;height:11.4pt;border-width:0 0 11pt 0;">RECONSTITUTION&nbsp;</span><span class="tx" style="left:474.8pt;width:47.9pt;height:11.4pt;border-width:0 10pt 11pt 0;">INJECTION</span><br/></div>
<div class="tb f748" style="font-size:8pt;top:686.98pt;left:34.36pt;"><span class="tx f738" style="width:5.9pt;height:10.3pt;border-width:0 0 0 19pt;">&#x2022;</span><span class="tx" style="left:23.8pt;width:37.2pt;height:9.9pt;border-width:0pt 18pt 0 0;">&nbsp;1 aiguille </span><span class="tx" style="top:10pt;width:59pt;height:9.9pt;border-width:0 10pt 11pt 11pt;">(38 mm - 20 G)</span><br/></div>
<div class="tb f748" style="font-size:8pt;top:682.18pt;left:113.03pt;"><span class="tx f738" style="width:5.9pt;height:10.3pt;border-width:0 0 0 11pt;">&#x2022;</span><span class="tx" style="left:15.9pt;width:73.8pt;height:9.9pt;border-width:0pt 10pt 0 0;">&nbsp;1 aiguille avec un  </span><span class="tx" style="top:10pt;width:79.1pt;height:9.9pt;border-width:0 10pt 0 11pt;">syst&#xe8;me de s&#xe9;curit&#xe9;  </span><span class="tx" style="top:19.6pt;width:59pt;height:9.9pt;border-width:0 22pt 11pt 20pt;">(38 mm - 20 G)</span><br/></div>
<div class="tb f748" style="font-size:8pt;top:686.98pt;left:212.93pt;"><span class="tx f738" style="width:5.9pt;height:10.3pt;border-width:0 0 0 19pt;">&#x2022;</span><span class="tx" style="left:23.8pt;width:37.2pt;height:9.9pt;border-width:0pt 18pt 0 0;">&nbsp;1 aiguille </span><span class="tx" style="top:10pt;width:59pt;height:9.9pt;border-width:0 10pt 11pt 11pt;">(38 mm - 20 G)</span><br/></div>
<div class="tb f748" style="font-size:8pt;top:686.98pt;left:306.48pt;"><span class="tx f738" style="width:5.9pt;height:10.3pt;border-width:0 0 0 19pt;">&#x2022;</span><span class="tx" style="left:23.8pt;width:37.2pt;height:9.9pt;border-width:0pt 18pt 0 0;">&nbsp;1 aiguille </span><span class="tx" style="top:10pt;width:59pt;height:9.9pt;border-width:0 10pt 11pt 11pt;">(38 mm - 20 G)</span><br/></div>
<div class="tb f748" style="font-size:8pt;top:686.98pt;left:397.18pt;"><span class="tx f738" style="width:5.9pt;height:10.3pt;border-width:0 0 0 19pt;">&#x2022;</span><span class="tx" style="left:23.8pt;width:37.2pt;height:9.9pt;border-width:0pt 18pt 0 0;">&nbsp;1 aiguille </span><span class="tx" style="top:10pt;width:59pt;height:9.9pt;border-width:0 10pt 11pt 11pt;">(38 mm - 20 G)</span><br/></div>
<div class="tb f748" style="font-size:8pt;top:682.18pt;left:475.85pt;"><span class="tx f738" style="width:5.9pt;height:10.3pt;border-width:0 0 0 11pt;">&#x2022;</span><span class="tx" style="left:15.9pt;width:73.8pt;height:9.9pt;border-width:0pt 10pt 0 0;">&nbsp;1 aiguille avec un  </span><span class="tx" style="top:10pt;width:76.8pt;height:9.9pt;border-width:0 13pt 0 11pt;">syst&#xe8;me de s&#xe9;curit&#xe9; </span><span class="tx" style="top:19.6pt;width:59pt;height:9.9pt;border-width:0 22pt 11pt 20pt;">(38 mm - 20 G)</span><br/></div>
<div class="tb f748" style="font-size:12pt;letter-spacing:1.2pt;top:506.34pt;left:32.29pt;"><span class="tx" style="width:254.8pt;height:14.9pt;border-width:0 0 11pt 11pt;">CONTENU DES BO&#xce;TES DE D&#xc9;CAPEPTYL</span><span class="tx" style="font-size:7pt;letter-spacing:0pt;left:264.8pt;width:6.3pt;height:8.7pt;border-width:1pt 0 16pt 0;">&#xae;</span><span class="tx" style="left:271.1pt;width:24.7pt;height:14.9pt;border-width:0 10pt 11pt 0;">&nbsp;L.<span style="width:0.45em;">P</span>.</span><br/></div>
<div class="tb f762" style="font-size:6pt;top:854.15pt;left:1.56pt;"><span class="tx" style="width:158.7pt;height:5.6pt;border-width:0 10pt 11pt 11pt;">REMIS BON USAGE_TRI-FR-000763_A4_09-2016.indd &nbsp;&nbsp;1</span><br/></div>
<div class="tb f762" style="font-size:6pt;top:854.15pt;left:532.84pt;"><span class="tx" style="width:50pt;height:5.6pt;border-width:0 10pt 11pt 11pt;">29/09/2016 &nbsp;&nbsp;10:08</span><br/></div>
</div>
